ArticleFEMS yeast research2024

A multidimensional assessment of in-host fitness costs of drug resistance in the opportunistic fungal pathogen Candida glabrata.

Amir Arastehfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.